Concepts (271)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebellum | 3 | 2021 | 94 | 1.560 |
Why?
|
| Dementia | 14 | 2025 | 280 | 1.470 |
Why?
|
| Synapses | 2 | 2021 | 195 | 1.040 |
Why?
|
| Locomotion | 3 | 2018 | 111 | 1.010 |
Why?
|
| Behavior, Animal | 5 | 2018 | 234 | 0.920 |
Why?
|
| Hypothalamus | 2 | 2016 | 134 | 0.920 |
Why?
|
| Monitoring, Ambulatory | 3 | 2017 | 56 | 0.870 |
Why?
|
| Circadian Rhythm | 2 | 2018 | 361 | 0.830 |
Why?
|
| Cell Phone | 3 | 2013 | 42 | 0.770 |
Why?
|
| Caregivers | 7 | 2025 | 294 | 0.760 |
Why?
|
| Gait Ataxia | 1 | 2021 | 3 | 0.700 |
Why?
|
| Complement C3 | 1 | 2021 | 60 | 0.680 |
Why?
|
| Nerve Tissue Proteins | 2 | 2021 | 428 | 0.590 |
Why?
|
| Mice, Inbred C57BL | 12 | 2021 | 3485 | 0.590 |
Why?
|
| Walking | 2 | 2012 | 245 | 0.580 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 3 | 2015 | 7 | 0.560 |
Why?
|
| Galectin 3 | 1 | 2018 | 9 | 0.550 |
Why?
|
| Motor Activity | 6 | 2016 | 345 | 0.530 |
Why?
|
| Aging | 3 | 2023 | 771 | 0.520 |
Why?
|
| Excitatory Amino Acids | 1 | 2016 | 1 | 0.500 |
Why?
|
| Independent Living | 3 | 2022 | 55 | 0.500 |
Why?
|
| Activities of Daily Living | 3 | 2017 | 293 | 0.490 |
Why?
|
| Feeding Behavior | 3 | 2017 | 263 | 0.490 |
Why?
|
| Vocalization, Animal | 1 | 2015 | 4 | 0.470 |
Why?
|
| Reflex, Startle | 1 | 2015 | 7 | 0.470 |
Why?
|
| Immunomagnetic Separation | 1 | 2015 | 9 | 0.460 |
Why?
|
| Synaptic Transmission | 1 | 2016 | 151 | 0.450 |
Why?
|
| Receptors, Serotonin | 3 | 2006 | 15 | 0.450 |
Why?
|
| Fear | 1 | 2015 | 71 | 0.450 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2014 | 99 | 0.440 |
Why?
|
| Phenotype | 2 | 2023 | 1233 | 0.420 |
Why?
|
| Mice | 17 | 2023 | 11119 | 0.420 |
Why?
|
| Wireless Technology | 1 | 2014 | 14 | 0.410 |
Why?
|
| Behavior | 1 | 2014 | 36 | 0.410 |
Why?
|
| Flow Cytometry | 1 | 2015 | 663 | 0.400 |
Why?
|
| Ecosystem | 2 | 2023 | 58 | 0.390 |
Why?
|
| Microglia | 1 | 2015 | 250 | 0.360 |
Why?
|
| Animals | 19 | 2023 | 21345 | 0.360 |
Why?
|
| Photometry | 1 | 2012 | 7 | 0.360 |
Why?
|
| Housing, Animal | 1 | 2012 | 15 | 0.360 |
Why?
|
| Mice, Knockout | 6 | 2021 | 2157 | 0.350 |
Why?
|
| Actigraphy | 1 | 2012 | 51 | 0.340 |
Why?
|
| Gait | 1 | 2012 | 121 | 0.330 |
Why?
|
| Exercise Test | 1 | 2012 | 257 | 0.320 |
Why?
|
| Medicare | 4 | 2023 | 625 | 0.310 |
Why?
|
| Stereotyped Behavior | 2 | 2009 | 9 | 0.290 |
Why?
|
| Software | 1 | 2012 | 400 | 0.280 |
Why?
|
| Piperazines | 2 | 2009 | 86 | 0.280 |
Why?
|
| Central Nervous System Stimulants | 2 | 2007 | 66 | 0.270 |
Why?
|
| Dextroamphetamine | 1 | 2007 | 3 | 0.270 |
Why?
|
| Male | 21 | 2025 | 31047 | 0.250 |
Why?
|
| Self Efficacy | 3 | 2025 | 205 | 0.230 |
Why?
|
| Gene Targeting | 1 | 2006 | 77 | 0.230 |
Why?
|
| Ethanol | 2 | 2023 | 330 | 0.230 |
Why?
|
| Quality of Life | 2 | 2024 | 1260 | 0.220 |
Why?
|
| Dopamine | 3 | 2012 | 108 | 0.220 |
Why?
|
| Gene Deletion | 1 | 2006 | 312 | 0.210 |
Why?
|
| Cerebral Cortex | 3 | 2012 | 269 | 0.210 |
Why?
|
| Aged | 18 | 2025 | 14965 | 0.210 |
Why?
|
| Terminal Care | 1 | 2025 | 119 | 0.210 |
Why?
|
| Female | 20 | 2025 | 34018 | 0.200 |
Why?
|
| Fetal Alcohol Spectrum Disorders | 1 | 2023 | 7 | 0.200 |
Why?
|
| Love | 1 | 2023 | 3 | 0.200 |
Why?
|
| Patient Navigation | 2 | 2025 | 36 | 0.190 |
Why?
|
| Potentially Inappropriate Medication List | 1 | 2022 | 15 | 0.190 |
Why?
|
| Cells, Cultured | 4 | 2021 | 2188 | 0.180 |
Why?
|
| Inappropriate Prescribing | 1 | 2022 | 68 | 0.180 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2023 | 155 | 0.180 |
Why?
|
| X-Ray Microtomography | 1 | 2021 | 27 | 0.170 |
Why?
|
| Calorimetry, Indirect | 1 | 2021 | 32 | 0.170 |
Why?
|
| Hand Strength | 1 | 2021 | 34 | 0.170 |
Why?
|
| Health Care Costs | 2 | 2023 | 223 | 0.170 |
Why?
|
| Alzheimer Disease | 5 | 2017 | 765 | 0.170 |
Why?
|
| Body Composition | 1 | 2021 | 155 | 0.170 |
Why?
|
| Catenins | 1 | 2020 | 14 | 0.160 |
Why?
|
| Humans | 26 | 2025 | 65140 | 0.160 |
Why?
|
| Point Mutation | 1 | 2000 | 168 | 0.160 |
Why?
|
| Middle Aged | 13 | 2025 | 18273 | 0.160 |
Why?
|
| Nebraska | 3 | 2019 | 6 | 0.150 |
Why?
|
| Energy Metabolism | 3 | 2016 | 399 | 0.150 |
Why?
|
| Brain | 4 | 2014 | 1605 | 0.150 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 407 | 0.150 |
Why?
|
| Health Services for the Aged | 1 | 2019 | 46 | 0.150 |
Why?
|
| Fee-for-Service Plans | 1 | 2019 | 71 | 0.140 |
Why?
|
| Knee Joint | 1 | 2021 | 310 | 0.140 |
Why?
|
| Aged, 80 and over | 8 | 2025 | 5614 | 0.140 |
Why?
|
| Delivery of Health Care | 2 | 2019 | 431 | 0.140 |
Why?
|
| Health Expenditures | 1 | 2019 | 121 | 0.140 |
Why?
|
| Calcium | 1 | 2021 | 584 | 0.140 |
Why?
|
| Continuity of Patient Care | 1 | 2019 | 174 | 0.130 |
Why?
|
| Autophagy | 1 | 2020 | 237 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 2 | 2016 | 868 | 0.130 |
Why?
|
| Apoptosis | 2 | 2021 | 1098 | 0.130 |
Why?
|
| Drinking | 1 | 2017 | 14 | 0.130 |
Why?
|
| Dendritic Cells | 1 | 2020 | 531 | 0.130 |
Why?
|
| HIV Infections | 2 | 2014 | 955 | 0.130 |
Why?
|
| Cognition | 1 | 2000 | 508 | 0.120 |
Why?
|
| Raclopride | 1 | 2015 | 2 | 0.120 |
Why?
|
| Ultrasonics | 1 | 2015 | 18 | 0.120 |
Why?
|
| Program Development | 1 | 2017 | 208 | 0.120 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2015 | 22 | 0.120 |
Why?
|
| Dopamine Antagonists | 1 | 2015 | 16 | 0.120 |
Why?
|
| Suspensions | 1 | 2015 | 9 | 0.120 |
Why?
|
| Algorithms | 2 | 2014 | 1050 | 0.110 |
Why?
|
| Cell Separation | 1 | 2015 | 147 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 856 | 0.110 |
Why?
|
| Telemedicine | 2 | 2017 | 362 | 0.110 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 211 | 0.110 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 1630 | 0.110 |
Why?
|
| Memory Disorders | 1 | 2014 | 52 | 0.110 |
Why?
|
| Mucociliary Clearance | 1 | 2014 | 6 | 0.100 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2014 | 13 | 0.100 |
Why?
|
| Axons | 1 | 2014 | 124 | 0.100 |
Why?
|
| Lasers | 1 | 2014 | 37 | 0.100 |
Why?
|
| Calibration | 1 | 2014 | 68 | 0.100 |
Why?
|
| Probability | 1 | 2014 | 170 | 0.100 |
Why?
|
| Remote Sensing Technology | 1 | 2013 | 6 | 0.100 |
Why?
|
| Gene Expression | 1 | 2016 | 852 | 0.100 |
Why?
|
| Cognition Disorders | 1 | 2014 | 223 | 0.100 |
Why?
|
| Disease Models, Animal | 1 | 2000 | 2293 | 0.100 |
Why?
|
| Movement | 1 | 2014 | 163 | 0.090 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2012 | 9 | 0.090 |
Why?
|
| Neurons | 2 | 2009 | 933 | 0.090 |
Why?
|
| Equipment Failure Analysis | 1 | 2012 | 78 | 0.090 |
Why?
|
| Single-Blind Method | 2 | 2023 | 142 | 0.090 |
Why?
|
| Recovery of Function | 1 | 2013 | 291 | 0.090 |
Why?
|
| Pneumonia | 1 | 2014 | 291 | 0.080 |
Why?
|
| Equipment Design | 1 | 2012 | 363 | 0.080 |
Why?
|
| Internet | 1 | 2014 | 467 | 0.080 |
Why?
|
| Intensive Care Units | 1 | 2013 | 420 | 0.080 |
Why?
|
| Adult | 5 | 2019 | 17358 | 0.080 |
Why?
|
| Substantia Nigra | 1 | 2009 | 14 | 0.080 |
Why?
|
| HIV-1 | 1 | 2014 | 706 | 0.070 |
Why?
|
| Aphasia | 1 | 2009 | 47 | 0.070 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 2008 | 4 | 0.070 |
Why?
|
| Temporal Lobe | 1 | 2009 | 46 | 0.070 |
Why?
|
| Neural Pathways | 1 | 2009 | 102 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2008 | 24 | 0.070 |
Why?
|
| Chromosome Inversion | 1 | 2008 | 18 | 0.070 |
Why?
|
| Apolipoprotein E4 | 1 | 2009 | 46 | 0.070 |
Why?
|
| Basal Ganglia | 1 | 2008 | 34 | 0.070 |
Why?
|
| Corpus Striatum | 1 | 2009 | 98 | 0.070 |
Why?
|
| Lung | 1 | 2014 | 966 | 0.070 |
Why?
|
| Tauopathies | 1 | 2008 | 17 | 0.070 |
Why?
|
| Pattern Recognition, Automated | 1 | 2007 | 52 | 0.070 |
Why?
|
| California | 2 | 2019 | 177 | 0.070 |
Why?
|
| Amyloid beta-Peptides | 1 | 2010 | 321 | 0.070 |
Why?
|
| tau Proteins | 1 | 2008 | 210 | 0.060 |
Why?
|
| United States | 4 | 2023 | 8093 | 0.060 |
Why?
|
| Cellular Senescence | 1 | 2008 | 121 | 0.060 |
Why?
|
| Mesencephalon | 1 | 2006 | 28 | 0.060 |
Why?
|
| NF-kappa B | 1 | 2008 | 435 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2006 | 181 | 0.060 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 296 | 0.060 |
Why?
|
| Telephone | 1 | 2025 | 122 | 0.050 |
Why?
|
| Interviews as Topic | 2 | 2019 | 531 | 0.050 |
Why?
|
| Hippocampus | 2 | 2020 | 276 | 0.050 |
Why?
|
| Cooperative Behavior | 1 | 2025 | 229 | 0.050 |
Why?
|
| Hyperkinesis | 1 | 2003 | 5 | 0.050 |
Why?
|
| Nucleoproteins | 1 | 2023 | 32 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2008 | 1008 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2006 | 663 | 0.050 |
Why?
|
| Cholinergic Antagonists | 1 | 2022 | 32 | 0.050 |
Why?
|
| Personal Satisfaction | 1 | 2023 | 82 | 0.050 |
Why?
|
| Polypharmacy | 1 | 2022 | 67 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2006 | 718 | 0.050 |
Why?
|
| Benzodiazepines | 1 | 2022 | 107 | 0.040 |
Why?
|
| Young Adult | 1 | 2012 | 4809 | 0.040 |
Why?
|
| Learning | 1 | 2023 | 186 | 0.040 |
Why?
|
| Mammals | 1 | 2023 | 222 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2023 | 302 | 0.040 |
Why?
|
| Autophagy-Related Protein 7 | 1 | 2020 | 6 | 0.040 |
Why?
|
| Emotions | 1 | 2023 | 233 | 0.040 |
Why?
|
| Pyramidal Cells | 1 | 2020 | 27 | 0.040 |
Why?
|
| San Francisco | 1 | 2019 | 10 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 203 | 0.040 |
Why?
|
| Neuropsychological Tests | 2 | 2013 | 410 | 0.040 |
Why?
|
| Age Factors | 2 | 2014 | 1586 | 0.040 |
Why?
|
| Dementia, Vascular | 1 | 2019 | 12 | 0.040 |
Why?
|
| Lewy Body Disease | 1 | 2019 | 15 | 0.040 |
Why?
|
| Atrophy | 2 | 2009 | 87 | 0.040 |
Why?
|
| Consumer Behavior | 1 | 2019 | 38 | 0.040 |
Why?
|
| Genotype | 2 | 2012 | 673 | 0.030 |
Why?
|
| Amphetamine | 2 | 2009 | 12 | 0.030 |
Why?
|
| Dopamine Agonists | 2 | 2009 | 22 | 0.030 |
Why?
|
| Benzazepines | 2 | 2009 | 21 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 317 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2023 | 570 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2012 | 509 | 0.030 |
Why?
|
| Pharmacists | 1 | 2019 | 130 | 0.030 |
Why?
|
| Depression | 1 | 2024 | 900 | 0.030 |
Why?
|
| Iowa | 1 | 2017 | 21 | 0.030 |
Why?
|
| Focus Groups | 1 | 2019 | 319 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2000 | 1290 | 0.030 |
Why?
|
| Smartphone | 1 | 2017 | 73 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 1994 | 0.030 |
Why?
|
| Wearable Electronic Devices | 1 | 2017 | 76 | 0.030 |
Why?
|
| Pregnancy | 1 | 2023 | 2372 | 0.030 |
Why?
|
| Mobile Applications | 1 | 2017 | 140 | 0.030 |
Why?
|
| Medicaid | 1 | 2019 | 372 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 496 | 0.030 |
Why?
|
| Procaterol | 1 | 2014 | 1 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2014 | 116 | 0.030 |
Why?
|
| Protein Kinase C-alpha | 1 | 2014 | 17 | 0.030 |
Why?
|
| Caprylates | 1 | 2014 | 15 | 0.030 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2014 | 34 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2014 | 526 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 591 | 0.020 |
Why?
|
| Models, Animal | 1 | 2014 | 241 | 0.020 |
Why?
|
| Motor Skills | 1 | 2013 | 61 | 0.020 |
Why?
|
| Executive Function | 1 | 2013 | 68 | 0.020 |
Why?
|
| Mental Disorders | 1 | 2000 | 822 | 0.020 |
Why?
|
| Cilia | 1 | 2014 | 156 | 0.020 |
Why?
|
| Valine | 1 | 2012 | 32 | 0.020 |
Why?
|
| Frontotemporal Lobar Degeneration | 1 | 2012 | 20 | 0.020 |
Why?
|
| Methionine | 1 | 2012 | 57 | 0.020 |
Why?
|
| Memory | 1 | 2013 | 123 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2013 | 213 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2014 | 413 | 0.020 |
Why?
|
| Prefrontal Cortex | 1 | 2012 | 127 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2013 | 296 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 2757 | 0.020 |
Why?
|
| Alleles | 1 | 2012 | 453 | 0.020 |
Why?
|
| Frontotemporal Dementia | 1 | 2012 | 157 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2013 | 1015 | 0.020 |
Why?
|
| Grooming | 1 | 2009 | 4 | 0.020 |
Why?
|
| Dopamine Agents | 1 | 2009 | 11 | 0.020 |
Why?
|
| Autoradiography | 1 | 2009 | 52 | 0.020 |
Why?
|
| Syndrome | 1 | 2009 | 180 | 0.020 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2009 | 26 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2009 | 89 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2013 | 519 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2010 | 196 | 0.020 |
Why?
|
| Parietal Lobe | 1 | 2009 | 28 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2009 | 122 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2010 | 232 | 0.020 |
Why?
|
| Haplotypes | 1 | 2008 | 134 | 0.020 |
Why?
|
| Mice, Inbred CBA | 1 | 2008 | 80 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2008 | 18 | 0.020 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2008 | 27 | 0.020 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2008 | 55 | 0.020 |
Why?
|
| Interleukins | 1 | 2008 | 88 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2009 | 240 | 0.020 |
Why?
|
| Interleukin-17 | 1 | 2008 | 99 | 0.020 |
Why?
|
| S100 Calcium Binding Protein G | 1 | 2006 | 7 | 0.020 |
Why?
|
| Calbindins | 1 | 2006 | 10 | 0.020 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2006 | 35 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 450 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2008 | 209 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 542 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2008 | 324 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2006 | 94 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2006 | 241 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2009 | 883 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 158 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 2701 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2009 | 1141 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2006 | 602 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2006 | 277 | 0.010 |
Why?
|
| Cell Survival | 1 | 2006 | 587 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 730 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 896 | 0.010 |
Why?
|
| Prognosis | 1 | 2009 | 1784 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2008 | 641 | 0.010 |
Why?
|
| X Chromosome | 1 | 2003 | 52 | 0.010 |
Why?
|
| Fasting | 1 | 2003 | 52 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 2244 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2009 | 3308 | 0.010 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2003 | 98 | 0.010 |
Why?
|
| Mutation | 1 | 2009 | 2661 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 788 | 0.010 |
Why?
|